Donglu Zhang

8.1k total citations · 1 hit paper
122 papers, 5.0k citations indexed

About

Donglu Zhang is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Donglu Zhang has authored 122 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 48 papers in Pharmacology and 46 papers in Oncology. Recurrent topics in Donglu Zhang's work include Pharmacogenetics and Drug Metabolism (47 papers), Drug Transport and Resistance Mechanisms (22 papers) and HER2/EGFR in Cancer Research (11 papers). Donglu Zhang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (47 papers), Drug Transport and Resistance Mechanisms (22 papers) and HER2/EGFR in Cancer Research (11 papers). Donglu Zhang collaborates with scholars based in United States, Germany and Sweden. Donglu Zhang's co-authors include W. Griffith Humphreys, Haiying Zhang, Charles Frost, Mingshe Zhu, Donald Pinto, Pancras C. Wong, Nirmala Raghavan, Kenneth L. Ray, Kan He and Shiang-Yuan Chen and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Donglu Zhang

117 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans

2008 490 citations Nirmala Raghavan, Charles Frost et al. Drug Metabolism and Disposition profile →

Peers

Countries citing papers authored by Donglu Zhang

Since Specialization

Citations

This map shows the geographic impact of Donglu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donglu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donglu Zhang more than expected).

Fields of papers citing papers by Donglu Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donglu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donglu Zhang. The network helps show where Donglu Zhang may publish in the future.

Co-authorship network of co-authors of Donglu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Donglu Zhang. A scholar is included among the top collaborators of Donglu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donglu Zhang. Donglu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of hydrolase activity in ocular tissues of humans and preclinical species 2025 ·Drug Metabolism and Disposition ·(unknown), Donglu Zhang, Robert S. Jones, Lionel Cheruzel, S. Cyrus Khojasteh, Hsu-Hsin Chen, Emel Adaligil, (unknown), Leah A. Owen, Ivana K. Kim, Margaret M. DeAngelis, Bin Ma	2
2	Biotransformation of protein degraders bavdegalutamide and XL01126 in permeabilized cryopreserved human hepatocytes 2024 ·Drug Metabolism and Pharmacokinetics ·Bin Ma, Susan Wong, Joyce Liu, Jingwei Cai, Cyrus Khojasteh, Donglu Zhang	1
3	In vitro metabolism of targeted covalent inhibitors and their thiol conjugates by gut microbiome from rats, mice, and humans 2024 ·Drug Metabolism and Disposition ·Ting‐Jia Gu, Jingwei Cai, (unknown), Elizabeth Aparecida Ferraz da Silva Torres, Donglu Zhang, S. Cyrus Khojasteh, Shuai Wang	2
4	Discovery of Unprecedented Human Stercobilin Conjugates 2024 ·Drug Metabolism and Disposition ·Sungjoon Cho, Lionel Cheruzel, Jingwei Cai, Stephen K. Wrigley, (unknown), (unknown), Jonathan Steele, Laurent Salphati, Donglu Zhang, S. Cyrus Khojasteh	3
5	Development of Liposome Systems for Enhancing the PK Properties of Bivalent PROTACs 2023 ·Pharmaceutics ·(unknown), Elizabeth S. Levy, An D. Nguyen, Donglu Zhang, Shu Chen, (unknown), Xing Zhang, Fabio Broccatelli, Jennifer Pizzano, Jennifer Cantley, Elizabeth Bortolon, Emma Rousseau, Michael Berlin, Peter S. Dragovich, Vijay A. Sethuraman	12
6	Biotransformation novel advances – 2021 year in review 2022 ·Drug Metabolism Reviews ·S. Cyrus Khojasteh, Upendra A. Argikar, Sungjoon Cho, (unknown), (unknown), Kevin M. Johnson, Amit S. Kalgutkar, Lloyd King, (unknown), (unknown), Shuai Wang, Cong Wei, Donglu Zhang, Klarissa D. Jackson	3
7	An Integrated Strategy for Assessing the Metabolic Stability and Biotransformation of Macrocyclic Peptides in Drug Discovery toward Oral Delivery 2022 ·Analytical Chemistry ·(unknown), Shaofei Ji, Wei Wang, Susan Wong, Chun‐Wan Yen, (unknown), Dennis Leung, Emile G. Plise, Shu Zhang, Chenghong Zhang, (unknown), Donglu Zhang, Christian N. Cunningham, S. Cyrus Khojasteh, Dian Su	13
8	Intestinal Excretion, Intestinal Recirculation, and Renal Tubule Reabsorption Are Underappreciated Mechanisms That Drive the Distribution and Pharmacokinetic Behavior of Small Molecule Drugs 2021 ·Journal of Medicinal Chemistry ·Donglu Zhang, Cong Wei, Cornelis E. C. A. Hop, Matthew Wright, Ming Hu, Yurong Lai, S. Cyrus Khojasteh, (unknown)	19
9	Exposure-Efficacy Analysis of Antibody-Drug Conjugates Delivering an Excessive Level of Payload to Tissues 2019 ·Drug Metabolism and Disposition ·Donglu Zhang, Peter S. Dragovich, Shang‐Fan Yu, Yong Ma, Thomas H. Pillow, Jack Sadowsky, Dian Su, Wei Wang, Andrew G. Polson, S. Cyrus Khojasteh, Cornelis E. C. A. Hop	24
10	Intratumoral Payload Concentration Correlates with the Activity of Antibody–Drug Conjugates 2018 ·Molecular Cancer Therapeutics ·Donglu Zhang, Shang‐Fan Yu, S. Cyrus Khojasteh, Yong Ma, Thomas H. Pillow, Jack Sadowsky, Dian Su, Katherine R. Kozak, Keyang Xu, Andrew G. Polson, Peter S. Dragovich, Cornelis E. C. A. Hop	31
11	Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody–Drug Conjugates 2017 ·Cancer Research ·(unknown), Josefa Chuh, Yong Ma, Donglu Zhang, Katherine R. Kozak, Yichin Liu, Thomas H. Pillow, Jack Sadowsky, Tommy K. Cheung, Qui Phung, Benjamin Haley, (unknown), Robert W. Akita, Mark X. Sliwkowski, Andrew G. Polson	98
12	Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects 2013 ·American Journal of Cardiovascular Drugs ·(unknown), (unknown), Jessie Wang, Giridhar Tirucherai, Donglu Zhang, Rebecca A. Boyd, Charles Frost	121
13	ADME-enabling technologies in drug design and development 2012 ·Wiley eBooks ·Donglu Zhang, Sekhar Surapaneni	15
14	Metabolism, pharmacokinetics and pharmacodynamics of the factor Xa inhibitor apixaban in rabbits 2009 ·Journal of Thrombosis and Thrombolysis ·Donglu Zhang, Kan He, Nirmala Raghavan, Lifei Wang, Earl J. Crain, Bing He, Baomin Xin, Joseph M. Luettgen, Pancras C. Wong	17
15	The Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Ixabepilone: A First in Class Epothilone B Analogue in Late-Phase Clinical Development 2008 ·Clinical Cancer Research ·Sanjay Goel, Marvin L. Cohen, (unknown), Lionel Perrin, François André, David Jayabalan, Lisa Iacono, (unknown), (unknown), Donglu Zhang, Carrie Xu, (unknown), (unknown), Gary L. Goldberg, (unknown), Sridhar Mani	21
16	Drug metabolism in drug design and development : basic concepts and practice 2008 ·Wiley-Interscience eBooks ·Donglu Zhang, Mingshe Zhu, W. Griffith Humphreys	33
17	Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detection 2008 ·Rapid Communications in Mass Spectrometry ·Haiying Zhang, Mingshe Zhu, Kenneth L. Ray, Li Ma, Donglu Zhang	70
18	LC-MS/MS-Based Approach for Obtaining Exposure Estimates of Metabolites in Early Clinical Trials Using Radioactive Metabolites as Reference Standards 2007 ·Drug Metabolism Letters ·Donglu Zhang, Nirmala Raghavan, Theodore J. Chando, (unknown), Yunlin Fu, (unknown), Steve E. Unger, W. Griffith Humphreys	27
19	AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS 2004 ·Drug Metabolism and Disposition ·Donglu Zhang, Weiping Zhao, Vikram Roongta, James Mitroka, Lewis J. Klunk, (unknown)	15
20	CYP2D6 CATALYZES 5-HYDROXYLATION OF 1-(2-PYRIMIDINYL)-PIPERAZINE, AN ACTIVE METABOLITE OF SEVERAL PSYCHOACTIVE DRUGS, IN HUMAN LIVER MICROSOMES 2004 ·Drug Metabolism and Disposition ·Nirmala Raghavan, Donglu Zhang, Mingshe Zhu, Jianing Zeng, Lisa J. Christopher	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact